Ad26.RSV.preF vaccine

Adenovirus 26 vector-based RSV pre-F protein vaccine · Janssen Vaccines & Prevention B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ad26.RSV.preF vaccine, covering 2023-07-24 to 2023-07-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older [Phase 2]

See pricing